Generic drugs Bristol-Myers Squibb

Bristol-Myers Squibb licensed its AIDS drug, Reyataz, free of charge to two generic manufacturers in South Africa and India. This decision will make available the generic form of the drug to sub-Saharan Africa AIDS victims at affordable prices. Reyztaz was first marketed in the United States in 2003 and its patent expires in 2017. 

The Federal Trade Commission sues Bristol-Myers Squibb for blocking the sale of generic drugs, particularly the cancer drugs Platinol and Taxol and the antianxiety drug BuSpar. In a settlement, the company agrees not to engage in these types of unlawful behaviors. 

Note to Readers Most chemists know this compound as taxol, but it now has the generic name paclitaxel and the registered trade name Taxol (Bristol-Myers Squibb Company, New York, NY). Taxotere here refers to the drug now generically referred to as docetaxel with the registered trade name Taxotere (Rhone-Poulenc-Rorer Pharmaceuticals, Inc., Collegeville, PA). 

---